Apoptotic cell removal (efferocytosis) is an essential process in the regulation of inflammation and tissue repair. We have shown that monocyte-chemoattractant protein-1/CC chemokine ligand 2 (MCP-1/CCL2) enhances efferocytosis by alveolar macrophages in murine bacterial pneumonia. However, the mechanism by which MCP-1 exerts this effect remains to be determined. Here we explored that hypothesis that MCP-1 enhances efferocytosis through a Rac1/ phosphatidylinositol 3-kinase (PI3-kinase)-dependent mechanism.
anti-inflammatory mediators [1, 2] and several key growth factors [2, 3] . Efferocytosis of apoptotic polymorphonuclear neutrophils (PMNs) is crucial for resolution of acute inflammation in the lung [4, 5] . Thus, a defect or inefficiency of this process and accumulation of secondarily necrotic cells leads to persistent inflammation and tissue damage in the lung [2, 5, 6] . Knowledge about the mechanism of efferocytosis has been advanced considerably during recent years. Exposed phosphatidylserine(PS) on the outer leaflet of apoptotic cells is a major ligand that is recognized by phagocytes and is known as an 'eat me signal' [7] . Several bridge molecules and receptors for PS on phagocytes are reported to be essential molecules for recognition and removal of apoptotic cells [2, 8, 9] . On the other hand, it is not fully understood at molecular level how efferocytosis is facilitated at the beginning of resolution of acute inflammation in lung.
The importance of Rho-GTPases on efferocytosis is demonstrated in many studies and introduced in several reviews [10; 11] . Among so many known Rho-GTPases, classical Rho-GTPases such as Rac1, RhoA and Cdc42 are the most investigated. Rac1 and Cdc42 promote efferocytosis, whereas RhoA activation inhibits this process [8] .
Rac1 activation is considered to be especially important in efferocytosis through cytoskeltal, morphological changes and consequent membrane ruffles that form the phagocytic cup [12] . However, factors that up-regulate Rac1 activity followed by membrane ruffling for efferocytosis during resolution of acute inflammation remain to be elucidated.
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Monocyte chemoattractant protein-1/ CC chemokine ligand 2 (MCP-1/CCL2) is a member of the CC subgroup of the chemokine superfamily and is a ligand for the seven transmembrane domain G-protein-coupled receptor CCR2. MCP-1 also acts as a potent chemoattractant and activator of monocyte/macrophages [13] . Several studies show its protective effect during infection of Salmonella typhyimurium, Pseudomonas aeruginosa, [14] , and Streptococcus pneumoniae [15] in the murine peritoneal cavity and lung respectively. These studies imply that MCP-1 enhances lung immunity by recruiting mononuclear cells to fight infection. We have previously reported that MCP-1 enhances efferocytosis, followed by hepatocyte growth factor (HGF) production and plays a crucial role in resolution of inflammation and tissue repair in murine acute bacterial pneumonia model [5] . However the molecular mechanism by which MCP-1 enhances efferocytosis still remains to be elucidated. Recently, the MCP-1-CCR2 axis was reported to activate Rac1 and have a pivotal function on monocyte chemotaxis [16] .
This study evoked the hypothesis that MCP-1 enhances efferocytosis through Rac1 activation.
In the present study, we showed that MCP-1 enhances efferocytosis through Rac1-PI3K interaction using in vitro, ex vivo and in vivo approaches. These results indicate that MCP-1/Rac1/PI-3K pathway plays critical role in resolution of acute lung inflammation.
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Material and Methods
Animals and experimental protocol
Specific pathogen-free, 4 week old and 8 week old ICR and Balb/c mice were obtained from Charles River Japan (Kanagawa, Japan). The mice were provided with sterile food and water ad libitum in an environmentally controlled room. The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of Nagasaki University School of Medicine.
Lipopolysaccharide (LPS) induced lung injury; 1mg/kg of LPS was instilled intratracheally, then bronchoalveolar lavage [17] was performed at the time indicated.
Absolute macrophage and neutrophil counts were obtained by multiplying BAL leukocyte counts by differential cell counts. Bronchoalveolar lavage fluid (BALF) cytokines were measured using commercially available ELISA kits for murine MCP-1 (BIOSOURCE, Carlsbad, CA, USA), MIP-2 (RayBio, Norcross GA, USA) and TNFα (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions.
Reagents
Recombinant Mouse CCL2/JE/MCP-1 was purchased from R&D Systems (Minneapolis, MN, USA). Rac1 Inhibitor (NSC 23766) and PI3K inhibitor (LY 294002) were purchased from Calbiochem (San Diego, CA, USA). Lipopolysaccharide (E. Coli O111:B4) was purchased from SIGMA (St.Louis, MO, USA).
Isolation of Primary Cells
Human neutrophils were obtained from healthy donors and isolated via density gradient centrifugation as previously described [4] . Murine alveolar macrophage (AM) s were 7 isolated by whole lung lavage with PBS containing 100μM ethylenediaminetetraacetic acid (EDTA). Murine peritoneal macrophages (PM) s were isolated by lavage with PBS.
Murine thymocytes were isolated from the thymi of three to four week old, female ICR mice, by passing thymi through a 40-μm strainer (Fisher Scientific, Waltham, MA, USA) to separate individual cells.
Cell culture
Murine J774A.1 (J774)macrophages were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in Dulbecco's modified Eagle media (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2mM L-glutamine, 100 μg/ml streptomycin, and 100 U/ml penicillin in humidified 5% CO 2 at 37℃. Human leukemia Jurkat T cells were obtained from ATCC and cultured in RPMI 1640 supplemented with 10% heat-inactivated FBS, 2mM L-glutamine, 100 μg/ml streptomycin, and 100 U/ml penicillin in humidified 5% CO 2 at 37℃.
Induction of apoptosis
Apoptosis was induced in human neutrophils, Jurkat T cells, and murine thymocytes by exposure to UV irradiation at 312 nm (Fotodyne) for 10min as previously described [18] .
Human neutrophils were cultured in RPMI 1640 with 0.5%, low-endotoxin BSA (Sigma-Aldrich) for 2 h. Jurkat T cells and murine thymocytes were cultured in RPMI 1640 with 10% FBS at for 3 h in 5%CO 2 at 37℃.
In vitro phagocytosis assays
In vitro phagocytic assays were performed as previously described. Briefly, Quik(Sysmex,Kobe,Japan) staining. Phagocytosis was determined by visual inspection of samples by oil immersion light microscopy and was expressed as the phagocytic index (PI) as described [18] . Each condition was tested in duplicate and a minimum of 400 cells were counted per condition. In all cases, during analysis, the reader was blinded to the sample identification.
In vivo phagocytosis assays
The in vivo phagocytosis assay was performed using balb/c mice as previously described [18] . Mice were anesthetized with Nembutal (Dainippon Sumitomo Pharma, Osaka, Japan), following which 5×10 6 apoptotic human neutrophils, suspended in 50 μl of PBS, were instilled intratracheally. Three hours later, whole lung BAL was performed with a total of 5 ml of ice-cold PBS. Lavage cells were fixed and stained with Diff-Quik staining (Fisher Scientific, Pittsburgh, PA) and myeloperoxidase (MPO) staining using diaminobenzidine (DAB) substrate (Roche, Basel, Switzerland)
following the instruction manuals. Because AMs are originally negative for MPO 9 staining, MPO positivity in the cytoplasm of AMs were identified as engulfment of apoptotic neutrophils. The phagocytic index was assessed as described previously [5] .
The cell number in BALF was determined with the use of a hemocytometer. Cell differentials for BAL cells were assessed by Diff Quik stained samples.
Rac activation assay
The Rac activation assay was performed according to the manufacturer's instructions (Millipore, Billerica, MA) (pull-down method). Briefly, after each indicated treatment, cells were lysed, then cell lysates were incubated with the agarose -immobilized GST-PAK1, and co-precipitates were subjected to anti-Rac1 Western blot analysis.
To evaluate relative Rac activity of murine alveolar macrophages, another commercially available Rac activation assay (G-LISA®: Cytoskeleton Inc. Denver, CO) was used.
Overnight serum-starved murine AMs were treated same as above. The remainder of the protocol was followed as described in the kit manual. Briefly, snap frozen cell lysates were thawed and added to the Rho plate, binding Rho-GTP. The plate was washed, an antigen-presenting buffer was added, followed by primary and secondary antibodies.
The reaction was detected using horseradish peroxidase detection reagent followed by the stop buffer. The plate was read immediately by measuring absorbance at 490 nm on a microplate spectrophotometer.
Western Blotting
Western blotting was performed as previously described [18] .
Statistics
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Data were expressed as mean ± SE. Statistical analysis was performed by two-tailed Student's t test of unpaired samples. The Dunnett test was used for multiple comparisons. Significant differences were defined as p< 0.05.
RESULTS
The kinetics of MCP-1 differs from that of pro-inflammatory cytokines such as
MIP-2 and TNFαin acute lung inflammation (murine LPS induced lung injury model).
To show that MCP-1 plays an essential role in the resolution and repair processes during The number of macrophages ingesting neutrophils peaked at 48 hours and decreased thereafter, concomitantly with an increase in neutrophil number (Figure 1a and1b ).
Collectively, these results suggest that infiltrating neutrophils became apoptotic and were ingested by macrophages [19] . We then assessed MCP-1 levels in BALF. MCP-1 increased at 48 hours and reached a maximal level at 48-72 hours after LPS instillation, declining thereafter and returning to a basal level by 7 days (Figure 1c) . In contrast to MCP-1, MIP-2 and TNF-αshowed different kinetics in BALF, reaching a maximal level at 6 hours after LPS instillation which is much earlier than MCP-1 (Figure 1d ).
Macrophages express CCR2 constitutively.
Before testing the effect of MCP-1 on efferocytosis, we confirmed that murine J774s (a murine macrophage cell line), peritoneal and alveolar macrophages express CCR2 (Figure 2a ).
MCP-1 stimulation enhances efferocytosis in vitro.
We extended our previous work [5] by showing that MCP-1 enhances efferocytosis by J774s, as well as murine peritoneal and alveolar macrophages. Based on dose-response experiments from our previous study, we stimulated macrophages with MCP-1 at 10ng/ml. As shown, MCP-1 increased efferocytosis by J774s (Figure 2c 
Efferocytosis in vivo was up-regulated with MCP-1
As with our in vitro experiments, MCP-1 also enhanced efferocytosis by AMs in vivo (Figure 3a,b) . Considering that MCP-1 enhances monocyte chemotaxis and recruitment, we were concerned that MCP-1 may increase the number of AMs and thereby affect the phagocytic index. But the total number of AMs was similar in the presence or absence of MCP-1 (Figure 3c ).
MCP-1 activates Rac1 activity in macrophages.
To examine our hypothesis that MCP-1 may enhance efferocytosis by increasing Rac activation, Rac activation assays were performed. Significant Rac activation by MCP-1 on murine AMs was confirmed using the G-LISA assay (Figure 4a ). Rac pull-down assays also confirmed that MCP-1 increased Rac activation in J774 macrophages ( Figure 4b ) and murine PMs (Figure 4c ).
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MCP-1 upregulates efferocytosis by AMs through Rac1-PI3K (Phosphatidylinositol 3-kinase) pathway activation.
Rac activation is mediated by guanine nucleotide exchange factors (GEFs), like Trio and Tiam1 [20] . subsequent engulfment of the apoptotic cell [2, 8, 9] . In this process, two different roles of Rac1 have been demonstrated [12] . The first is to mobilize plasma membranes and establish lamellipodia, and the second is to regulate the actin dynamics during engulfment. Thus, Rac1 activation ahead of recognition of dying cells is crucial in the process of efferocytosis. We speculate that MCP-1 may play an important role by 15 preactivating Rac1 in alveolar macrophages during the resolution phase of acute lung inflammation.
We measured Rac1 activation in murine AMs using the G-LISA® assay because cell collection through BAL was not sufficient for western blot analysis. Our data showed that MCP-1 activates Rac1 compared to the control; however the magnitude of the change was small. We consider two reasons. First, the character of naïve, resident AMs are heterogeneous and expression of CCR2 is lower than blood monocytes [23] . Second,
RhoA is known to suppress Rac activity [10] . Therefore, the effect of MCP-1 on Rac1 activity in naïve AMs might be reduced due to simultaneous activation of RhoA by Focusing on respiratory medicine, MCP-1 has been recognized as an inflammatory chemokine that is present during acute and chronic inflammation. High expression of MCP-1 in chronic diseases, such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis and sarcoidosis [25, 26, 27] and the association between MCP-1-CCR2 and pathogenesis in bleomycin-induced mice pulmonary fibrosis has been reported [28] . The highly regulated kinetics of MCP-1 during acute inflammation In LPS-induced lung inflammation, resident alveolar macrophages are replaced by recruited alveolar macrophages in some proportion [30] , and recruited alveolar macrophages have higher phagocytic activity than resident macrophages [24] . As discussed above, we used naïve resident alveolar macrophages. This is our limitation and would be our next process for further analysis to see the effect of MCP-1/CCL2 on alveolar macrophages initiated by microorganisms or proinflammatory cytokines and recruited alveolar macrophages. The baseline Rac1 activity or Rac1/RhoA balance in alveolar macrophages might be involved in their phagocytic activity [18] . Conceivably, baseline RhoGTPase activity in naïve alveolar macrophages might be at RhoA > Rac1 17 balance, and once inflammation begins to resolve resident macrophages and recruited macrophages might become Rac1 > RhoA so that effective engulfment takes place in the lung. We speculate that transient elevation of MCP-1 in resolution phase might work to switch from RhoA-balanced to Rac1-balanced state in the AM during acute lung inflammation.
Our findings in this study revealed the importance of Rac1-PI3K pathway in mechanism of positive regulation on efferocytosis by MCP-1 during the resolution of acute lung inflammation. Therefore, we consider that dysregulation of MCP-1-Rac1-PI3K axis in resolution phase might lead the transition to persistent, chronic inflammation. 
